Copyright © 2004, European Society of Cardiology
The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle
Howard Florey Institute, University of Melbourne, Victoria 3010, Australia
* Corresponding author. Tel.: +61 3 8344 1961; fax: +61 3 9348 1707. Email address: g.dusting{at}hfi.unimelb.edu.au Grant.Drummond{at}med.monash.edu.au
Objective: NADPH oxidases are important sources of reactive oxygen species (ROS) in the vasculature. In phagocytic cells, the catalytic subunit of NADPH oxidase is a glycoprotein, gp91phox. However, vascular smooth muscle cells (VSMCs), which show prominent NADPH oxidase activity, lack gp91phox. Hence, we examined the role of Nox4, a gp91phox homologue, in superoxide production in mouse-cultured VSMCs.
Methods and results: Incubation of VSMCs with NADPH increased ROS production whether detected by lucigenin-enhanced chemiluminescence or dichlorofluorescein. Superoxide production was inhibited by the NADPH oxidase inhibitors, diphenyleneiodonium and apocynin, but not by inhibitors of other potential sources of superoxide. In unstimulated VSMCs, phosphorothioate antisense oligonucleotides against Nox4 down-regulated mRNA expression of the subunit by 65% and attenuated superoxide production by 41% without affecting Nox1 expression. Interleukin-1β (IL-β) thrombin and platelet-derived growth factor (PDGF) also reduced Nox4 mRNA expression after 3 h without affecting Nox1 levels. Of these stimuli, only IL-β reduced superoxide, but this effect was more rapid (
30 min) than its actions on Nox4.
Conclusions: Under resting conditions, NADPH oxidase activity in VSMCs is largely dependent upon Nox4 expression. Proinflammatory mediators down-regulated Nox4 but did not affect Nox1 expression, so other factors must compensate to regulate superoxide production.
1 Current address: Department of Pharmacology, Monash University, Victoria 3800, Australia. Tel.: +61 3 9905 4869; fax: +61 3 9905 5851.
Time for primary review 21 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. J. McCrann, A. Eliades, M. Makitalo, K. Matsuno, and K. Ravid Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy Blood, August 6, 2009; 114(6): 1243 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Wilson, C. C. Cavanagh, A. M. Lesher, A. J. Frey, S. E. Russell, and E. M. Smyth Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species J. Lipid Res., June 1, 2009; 50(6): 1047 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gao and G. E. Mann Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling Cardiovasc Res, April 1, 2009; 82(1): 9 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Schroder, K. Wandzioch, I. Helmcke, and R. P. Brandes Nox4 Acts as a Switch Between Differentiation and Proliferation in Preadipocytes Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 239 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Anilkumar, R. Weber, M. Zhang, A. Brewer, and A. M. Shah Nox4 and Nox2 NADPH Oxidases Mediate Distinct Cellular Redox Signaling Responses to Agonist Stimulation Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1347 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Clempus, D. Sorescu, A. E. Dikalova, L. Pounkova, P. Jo, G. P. Sorescu, B. Lassegue, and K. K. Griendling Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Rickard, J. W. Funder, P. J. Fuller, and M. J. Young The Role of the Glucocorticoid Receptor in Mineralocorticoid/Salt-Mediated Cardiac Fibrosis Endocrinology, December 1, 2006; 147(12): 5901 - 5906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Jiang, S. J. Roberts, S. r. Datla, and G. J. Dusting NO Modulates NADPH Oxidase Function Via Heme Oxygenase-1 in Human Endothelial Cells Hypertension, November 1, 2006; 48(5): 950 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Clempus and K. K. Griendling Reactive oxygen species signaling in vascular smooth muscle cells Cardiovasc Res, July 15, 2006; 71(2): 216 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Judkins, C. G. Sobey, T. T. Dang, A. A. Miller, G. J. Dusting, and G. R. Drummond NADPH-Induced Contractions of Mouse Aorta Do Not Involve NADPH Oxidase: A Role for P2X Receptors J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 644 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Piper and E. A. Martinson Cardiovascular Research speeds up-Even more Cardiovasc Res, March 1, 2006; 69(4): 773 - 776. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Miller, G. R. Drummond, H. H.H.W. Schmidt, and C. G. Sobey NADPH Oxidase Activity and Function Are Profoundly Greater in Cerebral Versus Systemic Arteries Circ. Res., November 11, 2005; 97(10): 1055 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Castier, R. P. Brandes, G. Leseche, A. Tedgui, and S. Lehoux p47phox-Dependent NADPH Oxidase Regulates Flow-Induced Vascular Remodeling Circ. Res., September 16, 2005; 97(6): 533 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zalba, O. Beloqui, G. S. Jose, M. U. Moreno, A. Fortuno, and J. Diez NADPH Oxidase-Dependent Superoxide Production Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Atherosclerotic Disease Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1452 - 1457. [Abstract] [Full Text] [PDF]
|
|